Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Arteriosclerosis, Thrombosis, and Vascular Biology is Scopus-indexed (Q1, CiteScore 12.2), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 1079-5642Verify ISSN ↗1524-4636Verify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 24 / 409 | 94th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1990–present, best quartile Q1, CiteScore 12.2.
Arteriosclerosis, Thrombosis, and Vascular Biology is Q1 in Cardiology and Cardiovascular Medicine (rank 24 of 409), by CiteScore 2025.
Arteriosclerosis, Thrombosis, and Vascular Biology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 12.2, which places it in quartile Q1 at the 94th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.884, quartile Q1, with an H-index of 310.
Arteriosclerosis, Thrombosis, and Vascular Biology is published by Lippincott Williams and Wilkins. Its print ISSN is 1079-5642 and its online ISSN is 1524-4636.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Arteriosclerosis, Thrombosis, and Vascular Biology has an h-index of 341 and a 2-year mean of 2.95 citations per paper (OpenAlex). Its Scopus CiteScore is 12.2, quartile Q1. On 2-year citations it ranks #65 of 398 Scopus journals in Cardiology and Cardiovascular Medicine.
Arteriosclerosis, Thrombosis, and Vascular Biology published 541 papers in 2025; its busiest recent year was 2019 with 889. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from United States (47.8%), China (15.9%) and Canada (6.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 28 retracted papers are recorded (1.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.